Prelude Capital Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-34,560
Closed -$82.6K 1454
2023
Q3
$82.6K Buy
34,560
+20,800
+151% +$46K 0.01% 1009
2023
Q2
$31.8K Sell
13,760
-42,133
-75% -$119K ﹤0.01% 995
2023
Q1
$143K Buy
55,893
+11,093
+25% +$31.8K 0.01% 913
2022
Q4
$112K Buy
+44,800
New +$125K 0.01% 1061
2022
Q2
Sell
-11,134
Closed -$89K 2156
2022
Q1
$89K Buy
+11,134
New +$98.2K ﹤0.01% 1436

Other funds holding SLGC

Prelude Capital Management's SLGC Position: Q4 2023 in Review

Prelude Capital Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 34,560 shares — an estimated $82.6K sold.

Prelude Capital Management first reported a position in SLGC in Q1 2022 and held it in 5 quarters. The position peaked at $143K in Q1 2023. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Prelude Capital Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 34,560 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $82.6K.
  • Prelude Capital Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q1 2022 and held it in 5 quarters.
  • Prelude Capital Management's SomaLogic, Inc. Class A Common Stock position peaked at $143K in Q1 2023.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.